Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs

The impact of disease-modifying therapies (DMTs) on the immune response to coronavirus disease-2019 (COVID-19) vaccines in persons with multiple sclerosis (pwMS) needs further elucidation. We investigated BNT162b2 mRNA COVID-19 vaccine effects concerning antibody seroconversion, inflammatory mediato...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazziotti, Valentina, Crescenzo, Francesco, Tamanti, Agnese, Dapor, Caterina, Ziccardi, Stefano, Guandalini, Maddalena, Colombi, Annalisa, Camera, Valentina, Peloso, Angela, Pezzini, Francesco, Turano, Ermanna, Marastoni, Damiano, Calabrese, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775192/
https://www.ncbi.nlm.nih.gov/pubmed/36551795
http://dx.doi.org/10.3390/biomedicines10123034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775192/
https://www.ncbi.nlm.nih.gov/pubmed/36551795
http://dx.doi.org/10.3390/biomedicines10123034

Ejemplares similares